THCX. Yes, we thought it was clever too.
We wanted to give investors a diversified, transparent, tax-efficient and liquid option to invest in the legal cannabis industry.
On the holdings page here which is updated daily.
Yes, the fund is passively managed and tracks the Innovation Labs Cannabis Index. The Bloomberg ticker for the index is “THCX Index”.
The annual fee is 0.70%. This includes a fee waiver of 25 bps until June 30, 2020.
Yes, please see our fact sheet here. It is updated quarterly and you can sign up to automatically receive it.
It is listed on NYSE Arca.
Check with your financial advisor or online broker to see if THCX is available on their platform. If it isn’t, please contact us. We are constantly working with new platforms to help on-board our ETF.
While a limit order is the safest route, it may take longer for your order to get executed. If you have specific questions about a larger order size, please feel free to contact us.
Yes, but it is best to check with your financial advisor first to understand the risks of shorting any ETF, not just THCX.
Yes, THCX options were listed on July 18, 2019.
While a specific date is impossible to pin down, first medicinal usage in China is estimated to be in the neighborhood of 2700 BC. Cannabis is believed to have first arrived in the Americas in 1545 AD courtesy of the Spanish.
While cannabis is often viewed as a recreational lifestyle item, there are many other applications including in the pharmaceutical market, as an additive to food and beverages, and for health and wellness products for not only humans but animals as well.
Currently, Canada and Uruguay are the only two countries with full federal legalization. Several other countries such as Colombia, Mexico, and Australia have legalized marijuana for medicinal usage. In the United States, marijuana legalization has remained elusive at the federal level. However recreational marijuana is legal in 10 states while medical marijuana is legal in 33.
CBD is short for Cannabidiol. It is a compound (one of >80 phytocannabinoids) found in the flower of the cannabis plant (either hemp or marijuana). CBD is believed to have non-addictive therapeutic benefits from both a medical and wellness standpoint with much of the research still in early stages.
CBD is non-psychoactive compared to THC (tetrahydrocannabinol) which has psychoactive effects. People often refer to CBD giving you a “body high” compared to a “head high” for THC.
The short answer is “no”. Both are derivations of the Cannabis Sativa family but the anatomy, composition and use cases are different. Hemp contains <0.3% THC while Marijuana has abundant levels of THC with concentrations ranging from 15% – 40%.
According to a February 21, 2019, research report by Seaport Global Securties, the global value today is over $12 billion with the potential to grow to $630 billion by 2040.